🦊/Investors

Zynext VenturesFull Portfolio

3 tracked investments · listed companies and verified rows first

Feldan Therapeuticsfeldan.cominApr 2025

Feldan is a clinical-stage biotech company developing intracellular delivery technologies for therapeutic treatment of diseases.

BiotechDeep TechMedical Devices

François-Thomas Michaud(Board Member & Chief Executive Officer)in

Co-investorsGenesys CapitalLinearis VenturesFonds de solidarité FTQ

Promaxopromaxo.comin𝕏Jun 2024

Promaxo develops a compact, office-based MRI system designed for point-of-care use, with applications including image-guided prostate interventions.

BiotechHardwareHealthtechMedical DevicesOakland, US

Amit Vohra(Executive Officer, Director)inMichael Bartholomew(Executive Officer, Director)inDinesh Kumar(Executive Officer)in

BoardJonathan Chen(Director)Derek Hennecke(Director)inDushyant Chipalkatty(Director)

Co-investorsAngel Physicians FundBand of AngelsFrontier Path VC

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Illexcor Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.